Citi analyst Geoff Meacham raised his price target on Protagonist Therapeutics (NASDAQ: PTGX) to $182 from $175, while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE